Universally accepted characterization standards for pluripotent and adult stem cells are needed to improve rigor and reproducibility. Standards set researchers up for success, ensure rigor in preclinical research, and ultimately strengthen the pipeline of therapies for patients. This program will present the latest draft of these standards, expected to be released in early 2023.